Cancer Research Career Enhancement and Related Activities

癌症研究职业提升及相关活动

基本信息

项目摘要

PROJECT SUMMARY: CANCER RESEARCH CAREER ENHANCEMENT As the only academic Cancer Center in its four-county catchment area (South Florida), the Sylvester Comprehensive Cancer Center (Sylvester) has a unique responsibility to provide cancer-focused education and training across the career continuum. Sylvester’s Office of Education and Training (OET) coordinates these activities, ensuring they meet and exceed the needs of diverse learners, including students, pre- and postdoctoral trainees, faculty, and healthcare professionals. Kerry L. Burnstein, PhD, Associate Director for Education and Training leads the OET, overseeing the strategic development, coordination, and evaluation of these efforts with assistance from Sylvester leadership and administration, Sylvester’s External Advisory Board, and the Cancer Education Leadership Council, an internal advisory committee comprising University leaders in education, training, and mentoring. They work together to achieve the career enhancement priorities identified in Sylvester’s 2014-2018 Strategic Plan to 1) Build and sustain cancer research careers through stage-specific scientific and professional development; and 2) Provide broad, crosscutting career enhancement and educational programs that facilitate collaborative, interdisciplinary cancer research. While many of the Center’s education and training activities are new, for the past 12 years the Cancer Biology Graduate (CAB) Program has successfully educated dozens of promising graduate students in basic or translational cancer research. Sylvester trainees have been productive and engaged in impactful cancer research; of the 150 publications highlighted by Sylvester’s three Research Programs, trainees were first or second author on 50%. Recently, Sylvester members received five cancer-focused or related T32 training grants, an international U54 grant with Argentina that has a significant education and training component, and an NCI K12 Calabresi award, which will begin enrolling physician scientists in 2019. To extend the impact of these grants, Sylvester will fund an additional trainee for the T32s awards and the K12. Sylvester supports traditional career enhancement activities such as distinguished lecture series, annual retreats, trainee speaking opportunities, and novel educational strategies including a nurse practitioner oncology fellowship and opportunities for medical students to work in medically underserved communities with cancer control experts. Given the unparalleled multicultural and linguistic diversity of the catchment area, Burnstein and the OET work with the University of Miami Clinical and Translational Science Institute leadership and Sylvester’s Associate Director for Population Science and Cancer Disparity to ensure that trainees receive didactic and experiential instruction on how cancer risk and outcome vary across populations, allowing them to consider and possibly incorporate this knowledge into their research design. Together these efforts foster a pipeline of highly motivated healthcare professionals and researchers, uniquely trained to solve the complex cancer-related problems in their communities and beyond.
项目摘要:癌症研究职业增强 作为其四县集水区(南佛罗里达州)的唯一学术癌症中心,西尔维斯特 综合癌症中心(Sylvester)有独特的责任来提供以癌症为中心的教育 和整个职业连续性培训。西尔维斯特教育与培训办公室(OET)坐标 这些活动,确保它们满足并超过包括学生在内的不同学习者的需求 博士后学员,教职员工和医疗保健专业人员。 Kerry L. Burnstein博士,副主任 教育和培训领导OET,监督战略发展,协调和评估 在西尔维斯特领导力和管理的协助下,西尔维斯特的外部咨询 董事会和癌症教育领导委员会,内部咨询委员会完成大学 教育,培训和心理领域的领导者。他们共同努力以实现职业增强优先事项 在西尔维斯特(Sylvester)的2014 - 2018年战略计划中确定1)通过 特定于阶段的科学和专业发展; 2)提供广泛的横切职业增强 以及促进跨学科癌症研究的教育计划。虽然许多 中心的教育和培训活动是新的,在过去的12年中,癌症生物学研究生(CAB) 计划成功地教育了数十名基本或翻译癌症的诺言研究生 研究。西尔维斯特学员一直在富有成效,并从事有影响力的癌症研究; 150 Sylvester的三个研究计划强调的出版物,受训者是第一或第二作者的50%。 最近,西尔维斯特成员获得了五个以癌症为中心或相关的T32培训补助金,这是国际U54 与阿根廷拥有重要的教育和培训部分的赠款,以及NCI K12 Calabresi奖, 这将在2019年开始入学。为了扩展这些赠款的影响,西尔维斯特将资助 T32S奖和K12的额外学员。西尔维斯特支持传统的职业增强 诸如杰出的讲座系列,年度务虚会,学员演讲机会和新颖的活动 教育策略,包括护士肿瘤学奖学金和医学生的机会 与癌症控制专家一起在医疗服务不足的社区工作。鉴于无与伦比的多元文化 以及集水区,伯恩斯坦和OET的语言多样性与迈阿密大学临床合作 转化科学研究所的领导力和西尔维斯特人口科学副总监 癌症差异以确保受训者获得有关癌症风险和如何风险的教学和专家指导 结果各不相同,使他们可以考虑并可能将这些知识纳入他们的知识 研究设计。这些努力共同促进了一支由积极进取的医疗保健专业人员和 研究人员,经过独特的培训,可以解决其社区及其他地区与癌症相关的复杂问题。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kerry L Burnstein其他文献

Kerry L Burnstein的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kerry L Burnstein', 18)}}的其他基金

Covid-19: Fast-tracking treatment by exploiting the steroid hormone receptor/TMPRSS2 axis
Covid-19:利用类固醇激素受体/TMPRSS2 轴进行快速治疗
  • 批准号:
    10814125
  • 财政年份:
    2021
  • 资助金额:
    $ 4.84万
  • 项目类别:
Covid-19: Fast-tracking treatment by exploiting the steroid hormone receptor/TMPRSS2 axis
Covid-19:利用类固醇激素受体/TMPRSS2 轴进行快速治疗
  • 批准号:
    10153099
  • 财政年份:
    2021
  • 资助金额:
    $ 4.84万
  • 项目类别:
Covid-19: Fast-tracking treatment by exploiting the steroid hormone receptor/TMPRSS2 axis
Covid-19:利用类固醇激素受体/TMPRSS2 轴进行快速治疗
  • 批准号:
    10341159
  • 财政年份:
    2021
  • 资助金额:
    $ 4.84万
  • 项目类别:
Cancer Research Career Enhancement and Related Activities
癌症研究职业提升及相关活动
  • 批准号:
    10443633
  • 财政年份:
    2019
  • 资助金额:
    $ 4.84万
  • 项目类别:
Cancer Research Career Enhancement and Related Activities
癌症研究职业提升及相关活动
  • 批准号:
    10670835
  • 财政年份:
    2019
  • 资助金额:
    $ 4.84万
  • 项目类别:
Cancer Research Career Enhancement and Related Activities
癌症研究职业提升及相关活动
  • 批准号:
    9789581
  • 财政年份:
    2019
  • 资助金额:
    $ 4.84万
  • 项目类别:
A Novel Drug Target for Aggressive Prostate Cancer
侵袭性前列腺癌的新药物靶点
  • 批准号:
    10083680
  • 财政年份:
    2018
  • 资助金额:
    $ 4.84万
  • 项目类别:
Vav3 Oncogene Potentiation of Androgen Receptor Signaling in Prostate Cancer.
Vav3 致癌基因对前列腺癌中雄激素受体信号传导的增强作用。
  • 批准号:
    8056479
  • 财政年份:
    2009
  • 资助金额:
    $ 4.84万
  • 项目类别:
Vav3 Oncogene Potentiation of Androgen Receptor Signaling in Prostate Cancer.
Vav3 致癌基因对前列腺癌中雄激素受体信号传导的增强作用。
  • 批准号:
    8459533
  • 财政年份:
    2009
  • 资助金额:
    $ 4.84万
  • 项目类别:
Vav3 Oncogene Potentiation of Androgen Receptor Signaling in Prostate Cancer.
Vav3 致癌基因对前列腺癌中雄激素受体信号传导的增强作用。
  • 批准号:
    8257572
  • 财政年份:
    2009
  • 资助金额:
    $ 4.84万
  • 项目类别:

相似海外基金

Understanding Ancestral Contribution to Lung Adenocarcinoma
了解祖先对肺腺癌的贡献
  • 批准号:
    10667660
  • 财政年份:
    2022
  • 资助金额:
    $ 4.84万
  • 项目类别:
Understanding Ancestral Contribution to Lung Adenocarcinoma
了解祖先对肺腺癌的贡献
  • 批准号:
    10615251
  • 财政年份:
    2022
  • 资助金额:
    $ 4.84万
  • 项目类别:
Understanding Ancestral Contribution to Lung Adenocarcinoma
了解祖先对肺腺癌的贡献
  • 批准号:
    10190280
  • 财政年份:
    2021
  • 资助金额:
    $ 4.84万
  • 项目类别:
Cancer Research Career Enhancement and Related Activities
癌症研究职业提升及相关活动
  • 批准号:
    10443633
  • 财政年份:
    2019
  • 资助金额:
    $ 4.84万
  • 项目类别:
Cancer Research Career Enhancement and Related Activities
癌症研究职业提升及相关活动
  • 批准号:
    10670835
  • 财政年份:
    2019
  • 资助金额:
    $ 4.84万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了